KeyCorp CEO exercises awards, nets 759,081 shares
KeyCorp Chairman and CEO Christopher M. Gorman reported multiple equity award transactions.
Rhea-AI Filing Summary
KeyCorp Chairman and CEO Christopher M. Gorman reported multiple equity award transactions. On February 17, 2026, he exercised restricted stock units into 130,037 common shares and had 51,080 shares withheld at $21.69 per share to cover tax obligations, leaving 759,081 common shares held directly.
On February 16, 2026, he received grants of 98,156 restricted stock units and an option to buy 107,413 shares, each vesting in four equal annual installments beginning February 17, 2027. He also reports indirect holdings of 200,000 and 250,000 common shares in grantor retained annuity trusts for himself and his children, and 5,251 shares in a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 25,734 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 32,462 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 41,237 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 30,604 | $0.00 | $0.00 |
| Exercise | Common Shares | 130,037 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Shares | 51,080 | $21.69 | $1.11M |
| Grant/Award | Restricted Stock Units | 98,156 | $0.00 | $0.00 |
| Grant/Award | Option to Buy | 107,413 | $0.00 | $0.00 |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Footnotes (14)
- F1. Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.
- F2. Includes approximately 198 common shares acquired under the KeyCorp Second Amended and Restated Discounted Stock Purchase Plan since September 2025.
- F3. These shares are held in a grantor retained annuity trust for the benefit of the reporting person and the reporting person's children. The reporting person is the trustee of the trust.
- F4. Reported as of February 9, 2026.
- F5. These restricted stock units, granted on February 16, 2026, vest in four equal annual installments beginning on February 17, 2027.
- F6. The option to buy, granted on February 16, 2026, vests in four equal annual installments beginning on February 17, 2027.
- F7. These restricted stock units, granted on February 14, 2022, vested in four equal annual installments ending on February 17, 2026.
- F8. Includes approximately 1,177 dividend-equivalent restricted stock units accrued between March and December 2025.
- F9. These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.
- F10. Includes approximately 2,968 dividend-equivalent restricted stock units accrued between March and December 2025.
- F11. These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.
- F12. Includes approximately 5,656 dividend-equivalent restricted stock units accrued between March and December 2025.
- F13. These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.
- F14. Includes approximately 5,596 dividend-equivalent restricted stock units accrued between March and December 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did KEY CEO Christopher M. Gorman report?
What new equity awards did the KeyCorp CEO receive in February 2026?
How do the grantor retained annuity trusts affect Gorman’s KeyCorp ownership?
When do Christopher Gorman’s new KeyCorp restricted stock units and options vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.